Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer RegistryJavier Gállego, Ismael Macías, Monserrat Mangas et al.|British Journal of Cancer|2017Cited by 106
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumabJavier Gállego, Ana Custodio, Alberto Carmona‐Bayonas et al.|British Journal of Cancer|2017Cited by 49
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with CancerAlberto Carmona‐Bayonas, Javier Gállego, Paula Jiménez‐Fonseca et al.|Thrombosis and Haemostasis|2019Cited by 28
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer RegistryJavier Gállego, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al.|Gastric Cancer|2017Cited by 20
Treatment of advanced gastric cancer based on Lauren’s histological: Real-world data from the AGAMEMON National Cancer RegistryAlberto Carmona‐Bayonas, Javier Gállego, Paula Jiménez‐Fonseca et al.|Annals of Oncology|2017Cited by 0